Mark Kaye

Executive Vice President and Chief Financial Officer Elevance Health

Last Reviewed: October 1, 2026

Executive Summary

Mark Kaye has been Elevance Health’s Chief Financial Officer since November 2023, and in 2026 also took over oversight of Carelon, the company’s healthcare services arm spanning pharmacy, behavioural health, value-based care and care delivery. Before Elevance he was chief financial officer of Moody’s for five years, after senior finance roles at MassMutual and Voya Financial and early work in investment banking at Credit Suisse First Boston. Elevance Health ranked No. 18 on the 2026 Fortune 500.

Career Highlights

• Executive Vice President and Chief Financial Officer of Elevance Health since November 2023.
• Oversight of Carelon since 2026.
• Executive Vice President and Chief Financial Officer of Moody’s, 2021 to 2023, and Senior Vice President and CFO, 2018 to 2021.
• Senior Vice President and Head of FP&A at MassMutual, 2016 to 2018.
• CFO and Senior Vice President, Retirement Solutions at Voya Financial, 2011 to 2015.

Professional Journey

Kaye began in investment banking at Credit Suisse First Boston and held senior financial and risk reporting roles at ING U.S. and ING Group. He was Chief Financial Officer and Senior Vice President of Retirement Solutions at Voya Financial from 2011 to 2015, then CFO of MassMutual U.S. and Head of Financial Planning and Analysis at MassMutual.

He joined Moody’s as Senior Vice President and Chief Financial Officer in August 2018, becoming Executive Vice President in 2021. He joined Elevance Health as CFO Designate in September 2023 and became Executive Vice President and Chief Financial Officer in November 2023. In February 2026 the company announced he would also oversee Carelon.

Education

No first-party source read for this profile states his education.